As of November 6, 2026, Shattuck Labs, Inc. is a publicly traded company (Nasdaq: STTK). The largest holder reporting an active stake on Schedule 13D is OrbiMed, at 9.99%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include T. Rowe Price (15.3%), Prosight Management, LP (9.9%), BlackRock (5.3%) (Schedule 13D/A, June 15, 2026).
Is this your company?
About to sign with, pay or invest in Shattuck Labs, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Shattuck Labs, Inc. a real, registered company?
- Shattuck Labs, Inc. files with the SEC under CIK 1680367 (its SEC filings).
- Its shares are listed under the ticker STTK on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Austin, Texas, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under SHATTUCK LABS, INC. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BlackRock (filed 2026-10-27).
Who are Shattuck Labs, Inc.'s owners and officers?
Shattuck Labs, Inc.: incorporated in Delaware; business address in Austin, Texas; industry Pharmaceutical Preparations (Schedule 13G, 2026-10-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-27 | Blackrock, Inc. | 5.3% |
| Schedule 13G/A, 2026-08-14 | T. Rowe Price Investment Management, Inc. | 15.3% |
| Schedule 13D/A, 2026-07-17 | Redmile Group, LLC | 9.9% |
| Schedule 13G, 2026-06-17 | Deep Track Capital, LP | 5.17% |
| Schedule 13D/A, 2026-06-15 | Orbimed Advisors LLC | 9.99% |
| Schedule 13D/A, 2026-06-11 | Redmile Group, LLC | 9.9% |
| Schedule 13G/A, 2026-05-15 | T. Rowe Price Investment Management, Inc. | 13.8% |
| Schedule 13G, 2026-02-06 | T. Rowe Price Investment Management, Inc. | 11.7% |
| Schedule 13G/A, 2025-11-13 | Prosight Management, LP | 9.9% |
| Schedule 13D, 2025-09-02 | Orbimed Advisors LLC | 9.99% |
| Schedule 13D/A, 2025-08-26 | Redmile Group, LLC | 9.9% |
| Schedule 13D/A, 2025-08-06 | Redmile Group, LLC | 11.8% |
Questions about who owns Shattuck Labs, Inc.
Who owns Shattuck Labs, Inc.?
On this page, 6 holders' latest ownership filings report 5% or more of Shattuck Labs, Inc.: T. Rowe Price Investment Management, Inc. (15.3%, Schedule 13G/A, filed 2026-08-14), Orbimed Advisors LLC (9.99%, Schedule 13D/A, filed 2026-06-15), Redmile Group, LLC (9.9%, Schedule 13D/A, filed 2026-07-17), Prosight Management, LP (9.9%, Schedule 13G/A, filed 2025-11-13) and Blackrock, Inc. (5.3%, Schedule 13G, filed 2026-10-27); 1 more is listed above.
Who are the largest shareholders of Shattuck Labs, Inc.?
By the share each holder's latest filing reports, the largest holders of Shattuck Labs, Inc. on this page are T. Rowe Price Investment Management, Inc. (15.3%), Orbimed Advisors LLC (9.99%) and Redmile Group, LLC (9.9%).
When did T. Rowe Price Investment Management, Inc. buy into Shattuck Labs, Inc.?
The filings give report dates, not purchase dates. The earliest filing from T. Rowe Price Investment Management, Inc. on this page is the Schedule 13G, filed 2026-02-06, reporting 11.7%; its latest, Schedule 13G/A filed 2026-08-14, reports 15.3%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Shattuck Labs, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Shattuck Labs, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Shattuck Labs, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
16 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Shattuck Labs, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director and 10% owner: 5,539,724 shares (5.4% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2024-12-06).
- Redmile Group, LLC, a director and 10% owner: 5,539,724 shares (5.4% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2024-12-06).
- , the chief executive and a director: 2,732,972 shares (2.7% of shares outstanding), 122,222 held directly and 2,610,750 indirectly (Form 4, 2026-05-13).
- OrbiMed Capital GP IX LLC, a director: 1,051,021 shares (1.0% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-06-15).
- OrbiMed, a director: 1,051,021 shares (1.0% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-06-15).
Shares outstanding: 101,842,552 as of 2026-11-02, from the company's latest SEC cover page.
How much has Shattuck Labs, Inc. raised?
No fundraising or offering filing from Shattuck Labs, Inc. is on file with us.
Keep reading
More on Shattuck Labs, Inc. and the records around it.
Shattuck Labs, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
Companies that share a holder
- Prosight Management, LP also filed stake reports on 5 other companies: OnKure Therapeutics, Inc. (Aug 2026), ADC Therapeutics SA (Feb 2026), MeiraGTx Holdings plc (Feb 2026)
- Redmile Group, LLC also filed stake reports on 18 other companies: FATE THERAPEUTICS INC (Nov 2026), Electra Therapeutics, Inc. (Sep 2026), Neurogene Inc. (Aug 2026)
- ORBIMED ADVISORS LLC also filed stake reports on 38 other companies: Aspen Neuroscience, Inc. (Nov 2026), ArriVent BioPharma, Inc. (Oct 2026), ADARx Pharmaceuticals, Inc. (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/shattuck-labs